New drug cuts the risk of death in bladder cancer by 30% compared with chemotherapy, study suggests
A new type of drug that targets chemotherapy directly to cancer cells reduces the risk of death from the most common type of bladder cancer by 30%, a phase III trial in the New England Journal of Medicine has suggested.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Drugs & Pharmacology | Study